Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study

BACKGROUND: Long-acting beta-agonists (LABA) and long-acting muscarinic antagonists (LAMA) combination therapy improved lung function and health-related quality-of-life and reduced exacerbation rates and dyspnea in symptomatic chronic obstructive pulmonary disease (COPD) patients. We compared the re...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Meng-Jer, Chen, Ning-Hung, Cheng, Shih-Lung, Tao, Chi-Wei, Wei, Yu-Feng, Wu, Yao-Kuang, Chan, Ming-Cheng, Liu, Shih-Feng, Hsu, Wu-Huei, Yang, Tsung-Ming, Lin, Ming-Shian, Liu, Ching-Lung, Kuo, Ping-Hung, Tsai, Ying-Huang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058003/
https://www.ncbi.nlm.nih.gov/pubmed/35510163
http://dx.doi.org/10.2147/COPD.S353799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058003/
https://www.ncbi.nlm.nih.gov/pubmed/35510163
http://dx.doi.org/10.2147/COPD.S353799

Ejemplares similares